Franklyn Health was proud to work with MediLife on a successful joint webinar exploring how to design MedTech clinical studies with market access and commercial success in mind. The session brought together two complementary perspectives – clinical research and market access – to help MedTech companies build evidence that goes beyond regulatory approval.
Delivered as part of BCN Health Innovation Week, powered by Biocat, BioRegion of Catalonia, the webinar reflected Franklyn Health’s growing reputation as a trusted leader in MedTech clinical research and its commitment to driving the conversations that shape commercial success in the medical technology sector.
A Powerful Collaboration Between CRO and Market Access Expertise
Rob Bedford and Laura Van Vaeck from Franklyn Health were joined by Ian Galloway and Alistair Kirby from MediLife, combining the unique perspectives of a specialist CRO and a market access expert in a single, high-value session.
The webinar brought together the full picture that emerging MedTech companies so often need – uniting clinical study design, regulatory strategy, market access, and reimbursement into one cohesive conversation. The result was a session that offered practical, real-world insight far richer than either perspective could provide alone, underlining the value Franklyn Health delivers through expert collaboration.
Key Takeaways from the Session
The webinar gave attendees practical guidance on how to design clinical studies that go beyond regulatory approval to support value demonstration; select endpoints and comparators that matter to payers and healthcare systems; avoid evidence gaps that can delay reimbursement or commercial uptake; and integrate market access thinking without overcomplicating early-stage clinical trials.
Are you a MedTech company looking for a CRO that understands your product, your pace, and your purpose?
Partner with Franklyn Health, where expertise meets agility, and your innovation becomes our mission.
Contact us to discuss your next medical device or diagnostic clinical study.
